Authors:
Choy, H
Devore, RF
Hande, KR
Porter, LL
Rosenblatt, P
Yunus, F
Schlabach, L
Smith, C
Shyr, Y
Johnson, DH
Citation: H. Choy et al., A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (A Vanderbilt cancer center affiliate network study), INT J RAD O, 47(4), 2000, pp. 931-937
Citation: Ml. Rothenberg et al., New drugs on the horizon: Matrix metalloproteinase inhibitors (reprinted from The Oncologist, vol 3, pg 271-274, 1998), STEM CELLS, 17(4), 1999, pp. 237-240
Authors:
Grunberg, SM
Crowley, J
Hande, KR
Giroux, D
Munshi, N
Lan, DHM
Schroder, LE
Zangmeister, MH
Balcerzak, SP
Hynes, HE
Gandara, DR
Citation: Sm. Grunberg et al., Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study, CANC CHEMOT, 44(6), 1999, pp. 461-468